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Abstract
Objectives To estimate fracture risk in patients receiving bariatric surgery
versus matched controls.
Design Population based, retrospective cohort study.
Setting Use of records from the United Kingdom General Practice
Research Database, now known as the Clinical Practice Research
Datalink (from January 1987 to December 2010).
Participants Patients with a body mass index of at least 30, with a record
of bariatric surgery (n=2079), and matched controls without a record
(n=10 442). Each bariatric surgery patient was matched to up to six
controls by age, sex, practice, year, and body mass index. Patients were
followed from the date of bariatric surgery for the occurrence of any
fracture. We used time dependent Cox regression to calculate relative
rates of fracture, adjusted for disease and previous drug treatment, and
time-interaction terms to evaluate fracture timing patterns.
Main outcome measure Relative rates of any, osteoporotic, and
non-osteoporotic fractures.
Results Mean follow-up time was 2.2 years. Overall, there was no
significantly increased risk of fracture in patients who underwent bariatric
surgery, compared with controls (8.8 v 8.2 per 1000 person years;
adjusted relative risk 0.89, 95% confidence interval 0.60 to 1.33). Bariatric
surgery also did not affect risk of osteoporotic and non-osteoporotic
fractures. However, we saw a trend towards an increased fracture risk
after three to five years following surgery, as well as in patients who had
a greater decrease in body mass index after surgery, but this was not
significant.
Conclusion Bariatric surgery does not have a significant effect on the
risk of fracture. For the first few years after surgery, these results are
reassuring for patients undergoing such operations, but do not exclude
a more protracted adverse influence on skeletal health in the longer
term.
Introduction
Obesity is an increasing public health problem worldwide. The
prevalence of obesity (body mass index >30), among middle
aged Europeans has been estimated as 15-20%.1 Data for the
prevalence of morbid obesity (bodymass index >40) are lacking
in Europe. In the United States, at least 5% of the population is
morbidly obese.2 It is now recognised that surgical treatment is
the most effective route to weight loss for people with morbid
obesity, accompanied by reduction of mortality and
improvement of comorbid conditions.3-5
Bariatric surgical procedures (conventionally grouped as
restrictive or malabsorptive) negatively affect bone remodelling,
as suggested by studies on bone resorption markers, and bone
mineral density. Restrictive procedures, such as vertical banded
gastroplasty and laparoscopic adjustable banding, have been
consistently reported to increase bone resorption,6-11 an increase
that is similar in magnitude to that observed in other forms of
weight reduction.8 Themechanisms behind the increase in bone
resorption after weight loss are not fully understood, but two
factors seem to be involved.
Firstly, reduced fat volumemay lead to a reduction in circulating
concentrations of oestrogens, which are partly synthesised in
adipose tissue.10 Secondly, a fall in leptin could result in an
increase in osteoclast recruitment and bone turnover.12 13
Malabsorptive procedures such as jejuno-ileal bypass and
bilio-pancreatic diversion have also been associated with an
increase of bone resorption and a decrease in bone mineral
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density14-19; contributory factors clearly include calcium and
vitamin Dmalabsorption, and secondary hyperparathyroidism.20
The Roux-en-Y gastric bypass surgery (a combined restrictive
and malabsorptive operation) is also associated with increased
bone resorption and decreased bone mineral density.14 21-27
Although evidence indicates that patients may have decreased
bone mineral density after bariatric surgery, the effect of the
procedure on fracture risk has not been determined. Furthermore,
the link between change in body mass index and fracture risk
is unknown. Therefore, the aims of this study were to estimate
the risk of fracture in patients with bariatric surgery compared
with morbidly obese patients who did not undergo surgery, and
to quantify the influence of the magnitude of body mass index
decrease after surgery on fracture risk.
Methods
Study population
A retrospective cohort study was conducted within the General
Practice Research Database, now known as the Clinical Practice
Research Datalink (www.cprd.com). The Clinical Practice
Research Datalink contains computerised medical records of
625 primary care practices in the United Kingdom, representing
8% of the population. The database provides detailed
information on demographics, drug prescriptions, clinical events,
specialist referrals, and hospital admissions. Previous studies
using the database have shown a high level of data validity with
respect to the reporting of fractures (>90% of fractures were
confirmed),28 and several systematic reviews have reported high
degrees of validity and completeness of other diagnoses or
smoking status.29-31
The study population consisted of all patients with a Clinical
Practice Research Datalink read code for bariatric surgery during
the period of valid data collection (from January 1987 to
December 2010). Gastrointestinal surgery for cancer was
excluded in this study, because cancer itself could influence
bonemetabolism. The index date was defined as the first record
for bariatric surgery. Bariatric surgery patients were only
included if they had a body mass index record with a value of
at least 30 at some point before surgery. Bariatric surgery
patients were stratified by surgical technique, including
adjustable gastric banding, Roux-en-Y gastric bypass, and other
techniques (for example, gastrectomy, and malabsorptive
procedures).
Selection of controls
Each patient was matched by age, sex, body mass index (within
a 10% difference), calendar time, and practice to up to six
patients without a history of bariatric surgery (at any time during
the study period). Body mass index entries were selected as the
latest record before surgery (measured at any time before the
index date).
Outcomes
We followed up patients from the index date to either the end
of data collection, the date of transfer of the patient out of the
practice area, the patient’s death, or fracture (Clinical Practice
Research Datalink read codes), whichever came first. Fracture
type was stratified according to World Health Organization
definitions into osteoporotic fracture (spine, hip, forearm, or
humerus) and non-osteoporotic fracture.32 33 For the analyses of
these two different fracture groups, we followed up all patients
for the occurrence of a fracture in the specific group, regardless
of whether a fracture had already occurred in the other group
(that is, patients could have sustained both an osteoporotic and
non-osteoporotic fracture).
Potential confounders
General risk factors considered in this study included age, sex,
smoking status (a record of currently smoking, ex-smoker, or
never smoked before; missing data were treated as a separate
category in the analyses), a record of falls in the previous 6-12
months (any fall recorded by the general practitioner; falls in
the previous six months were excluded), history of fracture,
history of a chronic disease (cerebrovascular disease, heart
failure, inflammatory bowel disease, asthma or chronic
obstructive pulmonary disease, anaemia, and dementia), and a
prescription in the previous six months for glucocorticosteroids,
antiobesity drugs, calcium or vitamin D supplements,
antihypertensive drugs, loop diuretics, hypnotics or anxiolytics,
antipsychotics, antidepressants, proton pump inhibitors, or
antiepileptic substances, and drugs for Parkinson’s disease
treatment.34-37 Age and the most recent record of body mass
index before the index date were handled as continuous variables
in the analyses.
Statistical analysis
We conducted two main analyses using stratified Cox
proportional hazards models (SAS 9.2, PHREG procedure;
stratified matched cohort analysis). The first analysis compared
the fracture rate in patients with bariatric surgery with that in
control patients (with the same body mass index), to yield an
estimate of the relative risk of fracture in bariatric surgery
patients (stratified by type of fracture and type of bariatric
surgical technique). We divided the total follow-up period into
30 day intervals. The presence of risk factors was assessed by
reviewing the computerised medical records of risk factors
before the start of an interval.We included potential confounders
in the final model if they independently changed the β
coefficient for bariatric surgery by at least 10%.
The second analysis studied the effect of excess loss in body
mass index after surgery on fracture risk (with the limit of
normality defined as body mass index of 25). For that purpose,
we divided all patients with bariatric surgery into four different
groups: those with no excess loss after surgery, those with
0-50% excess loss after surgery, those with at least 50% excess
loss after surgery, and those whose amount of excess loss was
unknown. We calculated excess loss as follows:
100×(preoperative body mass index−present body mass
index)÷(preoperative bodymass index−25). Based on this excess
loss, person time was allocated to one of these four defined
categories. In the event of no body mass index assessments in
that specific period, the person time was allocated to the
category in which excess loss was unknown.
We examined timing of fracture occurrence after bariatric
surgery by including time interaction terms (time
period×bariatric surgery) into the model for the following time
intervals: less than three months, three to 12 months, one to two
years, two to five years, and more than five years. Using
smoothing spline regression,38 we visualised the time trend for
risk of fracture for these given time intervals.
In a sensitivity analysis, we restricted bariatric surgery patients
to those with a body mass index record within two months
before bariatric surgery, and reset the index date for controls as
the date of most recent body mass index recording. These
analyses were further adjusted for calendar year and age at the
newly defined index date (along with all other confounders).
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;345:e5085 doi: 10.1136/bmj.e5085 (Published 6 August 2012) Page 2 of 11
RESEARCH
Our power analysis demonstrated a power of 88%, assuming a
relative risk of 1.6, a type I probability of 0.05, and based on
our cohort sizes (2079 bariatric surgery patients, with an average
of 5.02 matched controls per patient, and a fracture probability
in the control group of 2.0%).
Results
Baseline characteristics
Table 1⇓ shows baseline characteristics of bariatric surgery
patients andmatched controls.We identified 2079 patients who
underwent bariatric surgery (mean age 44.6 years, 83.9% female
patients, mean body mass index 43.2), and a total of 10 442
matched controls (mean age 44.9 years, 85.3%, 40.8). Adjustable
gastric banding was the most frequent surgical technique for
bariatric surgery (1249 (60%)), followed by Roux-en-Y gastric
bypass (613 (29%), fig 1⇓). The median difference between the
index date and most recent record of body mass index was 109
days (interquartile range 241) for patients who underwent
bariatric surgery and 321 days (680) for matched controls.
Bariatric surgery patients were more likely to have used
antidiabetics, antidepressants, anxiolytics or hypnotics, and
proton pump inhibitors in the previous six months. Total
duration of follow-up was 28 899 person years (mean 2.2 years
for bariatric surgery patients and 2.3 years for matched controls).
Overall risk of fracture
Table 2⇓ shows the overall risk of fracture in bariatric surgery
patients compared with matched controls, stratified by fracture
type. We did not observe an increase in overall risk for any
fracture (8.8 v 8.2 per 1000 person years; adjusted relative risk
0.89, 95% confidence interval 0.60 to 1.33), osteoporotic
fracture (0.67, 0.34 to 1.32), or non-osteoporotic fracture (0.90,
0.56 to 1.45). Similar rates for any fracture were observed
throughout the different surgical techniques.
Figure 2⇓ and table 3⇓ demonstrate the change in adjusted
relative risk with time after surgery, showing a modestly
increased risk over the first three months, followed by a
reduction and then a trend towards increasing fracture risk after
three to five years. However, none of these trends achieved
statistical significance, and overall there was no significant
interaction between bariatric surgery and time. Our sensitivity
analysis showed similar findings when we restricted the sets to
bariatric surgery with only recent records of body mass index.
Table 2 lists confounders that were included in the final adjusted
models.
Risk factors for fracture in bariatric surgery
patients
For bariatric surgery patients, use of anxiolytics in the previous
six months (adjusted relative risk 1.82, 95% confidence interval
1.06 to 3.15), and a history of cerebrovascular disease (8.26,
4.40 to 15.52) or previous fracture (2.44, 1.59 to 3.76) raised
the risk of fracture. Use of antidepressants, antidiabetics, proton
pump inhibitors, or statins within six months did not
significantly alter fracture risk within these patients (data not
shown).
Influence of excess reduction in body mass
index after surgery
Although we saw a trend towards an increased risk of fracture
with greater reduction of excess body mass index after surgery,
this was not significant (table 4⇓). However, this analysis had
limited statistical power. Thus, compared with patients with a
medium excess loss in body mass index (1-50%), the adjusted
relative risk was 0.32 (95% confidence interval 0.04 to 2.57) in
those with no excess loss in body mass index, and 1.46 (0.55
to 3.85) in those who lost over 50% of their excess body mass
index. The association between body mass index loss and
fracture risk remained similar after we included only patients
with a body mass index recording in the two months before
bariatric surgery.
Discussion
To our knowledge, this is the first study to investigate fracture
risk in patients who underwent bariatric surgery versus matched
controls. Although we observed a possible rise in fracture risk
at three to five years after surgery, overall, we were not able to
demonstrate a significantly increased risk of any,
non-osteoporotic, or osteoporotic fracture with bariatric surgery.
We saw a trend towards increasing fracture risk with greater
magnitude of excess reduction in bodymass index after bariatric
surgery, but again, this was not significant.
Comparison with other studies
Although no fracture studies have compared bariatric surgery
patients with matched controls so far, our findings are indirectly
supported by a meta-analysis by De Laet and colleagues.39 They
showed that a decrease in body mass index was less predictive
of fracture in obese patients (>30) than in those with a body
mass index of less than 30. For example, when comparing
patients with a body mass index of 15 and 20, the researchers
found a 3.7-fold elevated risk of hip fracture in the leaner
patients. However, when comparing those with a body mass
index of 30 and 35, the relative risk was much lower
(non-significant 1.1-fold increase in leaner patients). The authors
suggested that leanness is a much more important risk factor
for fracture, rather than considering obesity as a protective
factor. A study by Nakamura and colleagues estimated fracture
rates in bariatric surgery patients, but could not compare this
group with controls matched by body mass index.40 Although
they do suggest an increased risk based on expected age and
sex specific incidence, this difference may well be the effect of
obesity related comorbidities (as we have shown in our baseline
characteristics).
So far, studies on bariatric surgery and bone effects have been
limited to a number of reports on bone resorption markers and
bonemineral density.10-27Although the effect seemed to be small
and varied between studies, the results suggested that bariatric
surgery might negatively affect bone outcomes. For example,
Giusti and colleagues reported a slight decrease in bone mineral
density at the femoral neck (−5.8%), trochanter (−6.5%), but
not at the lumbar spine (+8.0%), two years after gastric banding
procedures.6 Similarly, Guney and colleagues showed a 9.9%
drop in bone mineral density at the femoral neck, one year after
vertical banded gastroplasty.6 10 The detrimental effect on bone
seemed to be less apparent with malabsorptive procedures. Ten
years after biliopancreatic diversion, a 4.2% decrease in spinal
bone mineral density was found, but no significant change in
hip bone mineral density.16 For the Roux-en-Y gastric bypass,
a combined restrictive and malabsorptive procedure, decreases
in femoral bone mineral density were found to be as low as
3.5% after two years,23 and as high as 10% after one year.27
The reduction in bone mineral density after bariatric surgery
may have several biological mechanisms. Firstly, a fall in bone
active adipocyte hormones (oestrogen and leptin) following
bariatric surgery may initiate bone loss. Oestrogen depletion
has been associated with vertical banded gastroplasty (22%
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reduction after one year),10 and is strongly linked to bone loss
in perimenopausal women.41 Decreased leptin levels as a result
of weight loss could enhance osteoclast activity and therefore
initiate bone loss,12 13 and alter the balance between osteoblast
and adipocyte formation.
Secondly, lowered levels of insulin and amylin could follow
weight loss, resulting in enhanced osteoclast recruitment and
inhibition of osteoblast activity.12 Thirdly, although evidence is
conflicting, malabsorptive procedures could be linked with
calcium and vitamin D deficiency (both are associated with a
decrease in bone mineral density and increased fracture risk).42
Since malabsorptive procedures (including combined restrictive
or malabsorptive procedures, such as the Roux-en-Y gastric
bypass) are more likely to lead to malnutrition (hypocalcaemia)
and vitamin deficiencies than restrictive procedures (for
example, gastric banding),43 risk of fracture could differ between
these surgical techniques. Although limited in statistical power,
our study did not observe such a difference in fracture risk
between gastric banding and Roux-en-Y gastric bypass. Finally,
the effect of bariatric surgery on bone might also depend not
only on the type of surgical procedure itself, but also on the
degree of sarcopenia caused or accelerated by marked weight
loss.
Alternatively, the observed decrease in bone mineral density
might be explained by measurement errors of bone mineral
density in morbidly obese patients.6Variability of bone mineral
density rises substantially when soft tissue depths exceed 25
cm.44Moreover, Madsen and colleagues showed that fat around
bone could falsely increase measured levels of bone mineral
density.45 As a consequence, reported falls in bone mineral
density at femoral and trochanter sites after bariatric surgery
could have been overestimated.
Strengths and limitations of the study
Our study has several strengths. To the best of our knowledge,
this is the first cohort of bariatric surgery patients in which the
risk of fracture has been investigated.We had a statistical power
of 88% to detect a relative risk of at least 1.6. Our data sources
had detailed longitudinal information on drug prescribing and
other risk factors for fracture, such as smoking status.
Furthermore, since 2004, bodymass index is very well registered
within the Clinical Practice Research Datalink (>85%), which
is a result of the introduction of the Quality Outcomes
Framework in 2004. This allowed us to match controls by body
mass index accurately, which is important given the association
between body weight and bone mineral density.12
A major limitation of this study was that body mass index was
not routinely collected over short time intervals. We therefore
selected themost recent recording of bodymass index, assuming
this information has not substantially changed over time (before
surgery). This lack of data also limited our statistical power in
the analysis evaluating the influence of excess reduction in body
mass index. Therefore, it was not possible to draw definite
conclusions about the role of the magnitude of reduction in body
mass index after bariatric surgery. Although obese patients
probably change weight continuously, and we did not have
information on body mass index at the exact day of bariatric
surgery, restricting the study population to those with records
in the previous two months did not substantially change the
results. Furthermore, the Clinical Practice Research Datalink
describes events that occurred or were recorded in general
practice. Events occurring in secondary or intermediary services
could therefore be incompletely ascertained. In addition, we did
not have information on bonemineral density, which could have
been useful for determining the underlying biological
mechanism in the association between bariatric surgery and
fracture.
We cannot exclude the possibility of confounding by
(contra)indication in this study. The National Institute for Health
and Clinical Excellence guidelines recommend bariatric surgery
in morbidly obese patients, preferably with coexisting diseases
(for example, type 2 diabetes and hypertension) that could be
improved by weight loss.43 We did not have information on
whether patients were considered for bariatric surgery and then
did not undergo an operation because of lack of associated
comorbidities. However, since these comorbidities were
probably not associated with reduced fracture rate, it is unlikely
that this consideration would reduce our ability to detect a
difference in fracture rate between bariatric surgery and control
patients.
Although a possibility of residual confounding due to
unmeasured unbalances between the two study groups still
exists, controls in this study seemed to be healthier (with fewer
obesity related comorbidities) than patients who underwent
bariatric surgery, and could therefore not have masked a true
association between bariatric surgery and fracture. Furthermore,
poor general fitness (associated with a loss in bone mineral
density) may be a reason to not undergo bariatric surgery.
Sjöström and colleagues showed that bariatric surgery patients
were more physically active than obese controls.46Although we
adjusted for factors such as hypertension and use of glucose
lowering drugs, we could not adjust for physical activity.
However, this healthy user bias would have probably resulted
in a decreased fracture risk shortly after surgery, whereas we
found a trend towards the opposite. It is usual for patients to
modify their diet before surgery to reduce the fat and glycogen
content of the liver. This diet may be based on solid or liquid
foods. We did not have information on perioperative diet, and
therefore were not able to adjust for this potential confounder,
but feel that such dietary change over the period of a few weeks
would be unlikely to substantially alter fracture risk, particularly
because the diet is aimed to preserve muscle tissue.
We used a widely accepted definition of osteoporotic and
non-osteoporotic fracture types, but it is difficult to be sure
about fracture cause based simply on fracture site, with no
information on the level of trauma. Finally, we had a relatively
short follow-up time (median time 2.2 years for bariatric surgery
patients), which yielded a reduced power to exclude an increase
in fracture risk beyond five years.
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Tables
Table 1| Baseline characteristics of bariatric surgery patients and controls matched by age, sex, and body mass index. Data are no (%) of
patients unless stated otherwise
Matched controls (n=10 442)Bariatric surgery patients (n=2079)Characteristic
2.3 (2.2)2.2 (2.1)Follow-up time (years)*
8904 (85.3)1744 (83.9)Female patients
44.9 (11.2)44.6 (11.1)Age at index date (years)*
40.8 (6.4)43.2 (7.2)Body mass index at index date*
Smoking status
5957 (57.0)1092 (52.5)Never
2293 (22.0)377 (18.1)Current
2100 (20.1)591 (28.4)Ex-smoker
92 (0.9)19 (0.9)Unknown
58 (0.6)22 (1.1)Falls (within previous 6-12 months)
History of disease ever before
1876 (18.0)407 (19.6)Fracture
120 (1.1)30 (1.4)Rheumatoid arthritis
156 (1.5)37 (1.8)Cerebrovascular disease
Drug use within previous 6 months
370 (3.5)89 (4.3)Glucocorticoids
174 (1.7)104 (5.0)Calcium or vitamin D supplements
576 (5.5)248 (11.9)Antiobesity drugs
1102 (10.6)401 (19.3)Antidiabetics
2050 (19.6)697 (33.5)Antidepressants
574 (5.5)203 (9.8)Anxiolytics or hypnotics
68 (0.7)8 (0.4)Bisphosphonates
271 (2.6)90 (4.3)Hormone replacement therapy
1315 (12.6)503 (24.2)Proton pump inhibitors
*Data are mean (standard deviation).
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Table 2| Risk of fracture in bariatric surgery patients compared with controls matched by age, sex, and bodymass index, by type of fracture
Adjusted relative risk (95% CI)†Crude relative risk (95% CI)*Fracture (no (%))
ReferenceReference207 (2.0)No bariatric surgery
0.89 (0.60 to 1.33)1.07 (0.74 to 1.54)38 (1.8)Any fracture after bariatric surgery
Type of bariatric surgery
0.82 (0.50 to 1.36)0.85 (0.53 to 1.36)21 (1.0)Gastric banding
0.77 (0.27 to 2.16)2.11 (0.98 to 4.56)9 (0.4)Roux-en-Y gastric bypass
1.28 (0.42 to 3.92)1.24 (0.51 to 3.01)8 (0.4)Other
Type of fracture
0.90 (0.56 to 1.45)1.01 (0.65 to 1.57)26 (1.3)Non-osteoporotic
0.67 (0.34 to 1.32)0.88 (0.47 to 1.64)13 (0.6)Osteoporotic
*Adjusted for age, sex, and most recent record of body mass index before the index date.
†Adjusted for age, sex, and most recent record of body mass index before the index date; a history of fracture, inflammatory bowel disease, and cerebrovascular
disease ever before; a history of falls in the previous 6-12 months; and use of glucocorticoids, calcium or vitamin D supplements, antiobesity drugs, antihypertensive
drugs, loop diuretics, organic nitrates, antidepressants, anxiolytics or hypnotics, bisphosphonates, opioids (tramadol or stronger), and proton pump inhibitors in
the previous six months.
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Table 3| Risk of any fracture in bariatric surgery patients and matched controls over time
Matched controlsBariatric surgery patients
Time since index date (months) Rate (%)*No of person yearsNo of eventsNo at riskRate (%)*No of person yearsNo of eventsNo at risk
0.7626192010 4421.01493520790-3
0.8366225597330.9812251219164-12
0.7961914972550.8011199139313-24
0.8375776347170.591357888825-60
0.9122002010031.193374170>60
*Calculated as the number of events divided by the number of person years in each period.
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Table 4| Risk of any fracture in bariatric surgery patients, by excess body mass index change during follow-up
Adjusted relative risk (95% CI)†Crude relative risk (95% CI)*Any fracture (no (%))
——38 (1.8)Any fracture after bariatric surgery
Excess loss in body mass index
0.32 (0.04 to 2.57)0.31 (0.04 to 2.49)1 (0.0)<0%
ReferenceReference9 (0.4)0-50%
1.46 (0.55 to 3.85)1.58 (0.61 to 4.11)8 (0.4)>50%
0.51 (0.23 to 1.15)0.56 (0.25 to 1.25)20 (1.0)Unknown
*Adjusted for age, sex, and most recent record of body mass index before the index date.
†Adjusted for confounders as shown in table 2.
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Figures
Fig 1 Number of bariatric surgery procedures performed between 1990 and 2010, by year and type of bariatric surgery
Fig 2 Spline regression plot of time since bariatric surgery and risk of any fracture in bariatric surgery patients versus
matched controls. Risk adjusted for confounders as shown in table 2
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